China Health Industries Holdings Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2024 to a ratio of 14.34, this represents a new company high. This is a clear indication for improving liquidity at China Health Industries Holdings Inc 's clients. Average receivable collection period, for the China Health Industries Holdings Inc in Mar 31 2024 quarter, has decreased to 25 days, compared to 57 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 75 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 842, from overall ranking in the second quarter 2024 at 3836.

What is Receivable Turnover Ratio?
What is China Health Industries Holdings Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CHHE Receivables Turnover Ratio	(Mar 31 2024) III. Quarter	(Dec 31 2023) II. Quarter	(Sep 30 2023) I. Quarter	(Jun 30 2023) IV. Quarter	(Mar 31 2023) III. Quarter
Y / Y Receivable Change	-91.03 %	-85.77 %	-83.62 %	-95.35 %	-24.1 %
Y / Y Revenue Change	-99.59 %	-99.86 %	11.07 %	-	2141500 %
Receivable Turnover Ratio (TTM)	14.34	6.37	5.38	3.8	2.21
CHHE's Total Ranking	# 842	# 3836	# 3836	# 3218	# 783
Accounts Receivable average collection period days	25	57	68	96	165
Seq. Receivable Change	-38.9 %	-8.99 %	221.29 %	-94.98 %	-3.06 %
Seq. Revenue Change	89.13 %	-99.88 %	66.3 %	7.54 %	-34.41 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 34
Healthcare Sector	# 76
Overall Market	# 842

Receivable Turnover Ratio Statistics
High	Average	Low
14.34	4.01	-0.01
(Mar 31 2024)		(Jun 30 2022)

CHHE Company Profile • Back to CHHE Efficiency Comparisons • Compare CHHE Receivables Turnover Ratio to its Competitors

Financial Statements
China Health Industries Holdings Inc 's Accounts Receivable	$ 0 Millions	Visit CHHE's Balance sheet
China Health Industries Holdings Inc 's Sales TTM	$ 0 Millions	Visit CHHE's Income Statement
Sources of CHHE's Revenues		Visit CHHE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CHHE's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CHHE's Growth Rates	CHHE's Roa	CHHE's Inventory Turnover Ratio	CHHE's Dividend Comparisons
CHHE's Profitability Ratios	CHHE's Roi	CHHE's Asset Turnover Ratio	CHHE's Dividend Growth
CHHE's Valuation Ratios	CHHE's Roe	CHHE's Financial Strength Ratios	CHHE's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2024	Receivable at quarter ending Mar 31 2024
Nature s Sunshine Products inc	44.22	$ 447.471 Millions	$ 10.120 Millions
Nektar Therapeutics	43.14	$ 90.167 Millions	$ 2.090 Millions
Renalytix Plc	43.00	$ 5.106 Millions	$ 0.119 Millions
Dih Holding Us Inc	40.01	$ 108.887 Millions	$ 2.721 Millions
Marpai Inc	39.39	$ 34.672 Millions	$ 0.880 Millions
Vivos Therapeutics Inc	38.54	$ 12.351 Millions	$ 0.321 Millions
Spero Therapeutics Inc	38.14	$ 110.979 Millions	$ 2.910 Millions
Cano Health Inc	36.41	$ 2,955.274 Millions	$ 81.171 Millions
Electrocore Inc	35.44	$ 17.889 Millions	$ 0.505 Millions
Lifemd Inc	34.57	$ 161.635 Millions	$ 4.675 Millions
Invo Fertility Inc	33.38	$ 4.249 Millions	$ 0.127 Millions
Prothena Corporation Public Limited Company	32.93	$ 89.251 Millions	$ 2.710 Millions
23andme Holding Co	32.38	$ 219.377 Millions	$ 6.776 Millions
Sonida Senior Living Inc	30.60	$ 260.687 Millions	$ 8.518 Millions
Plus Therapeutics Inc	30.08	$ 6.084 Millions	$ 0.202 Millions
Neuroone Medical Technologies Corp	26.83	$ 3.727 Millions	$ 0.139 Millions
Cv Sciences Inc	26.71	$ 14.790 Millions	$ 0.554 Millions
National Vision Holdings Inc	26.61	$ 2,106.622 Millions	$ 79.168 Millions
Vireo Growth Inc.	26.52	$ 93.132 Millions	$ 3.511 Millions
Ainos Inc	26.44	$ 0.094 Millions	$ 0.004 Millions
Clearside Biomedical Inc	25.87	$ 8.452 Millions	$ 0.327 Millions
Inmed Pharmaceuticals Inc	25.66	$ 6.218 Millions	$ 0.242 Millions
Cytomx Therapeutics Inc	22.78	$ 119.178 Millions	$ 5.233 Millions
Agenus Inc	22.51	$ 161.417 Millions	$ 7.171 Millions
U S Physical Therapy Inc	22.47	$ 611.968 Millions	$ 27.240 Millions
Innovage Holding Corp	22.22	$ 741.328 Millions	$ 33.362 Millions
Bespoke Extracts Inc	21.68	$ 0.957 Millions	$ 0.044 Millions
Kymera Therapeutics Inc	21.18	$ 79.413 Millions	$ 3.750 Millions
Orchestra Biomed Holdings Inc	20.96	$ 2.216 Millions	$ 0.106 Millions
Ginkgo Bioworks Holdings Inc	19.85	$ 208.697 Millions	$ 10.516 Millions

Date modified: 2026-09-08T15:11:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.